JPH0454101A - Preservation of kidney for implantation and preserving device of same kidney - Google Patents
Preservation of kidney for implantation and preserving device of same kidneyInfo
- Publication number
- JPH0454101A JPH0454101A JP16426290A JP16426290A JPH0454101A JP H0454101 A JPH0454101 A JP H0454101A JP 16426290 A JP16426290 A JP 16426290A JP 16426290 A JP16426290 A JP 16426290A JP H0454101 A JPH0454101 A JP H0454101A
- Authority
- JP
- Japan
- Prior art keywords
- kidney
- divalent
- aqueous solution
- trivalent iron
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003734 kidney Anatomy 0.000 title claims abstract description 70
- 238000002513 implantation Methods 0.000 title abstract 2
- 238000004321 preservation Methods 0.000 title description 7
- 239000007864 aqueous solution Substances 0.000 claims abstract description 23
- 238000001914 filtration Methods 0.000 claims abstract description 17
- 239000000243 solution Substances 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 150000002505 iron Chemical class 0.000 claims abstract description 11
- 210000002254 renal artery Anatomy 0.000 claims abstract description 8
- 210000002796 renal vein Anatomy 0.000 claims abstract description 7
- 210000000626 ureter Anatomy 0.000 claims abstract description 7
- 238000005406 washing Methods 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims description 14
- 159000000014 iron salts Chemical class 0.000 claims description 12
- 238000003860 storage Methods 0.000 claims description 11
- 238000002054 transplantation Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 18
- 229910052742 iron Inorganic materials 0.000 abstract description 9
- 238000006243 chemical reaction Methods 0.000 abstract description 7
- 230000006870 function Effects 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 5
- 150000003839 salts Chemical class 0.000 abstract description 5
- 230000006266 hibernation Effects 0.000 abstract description 4
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 229910017053 inorganic salt Inorganic materials 0.000 abstract 1
- 239000011664 nicotinic acid Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 10
- 230000008827 biological function Effects 0.000 description 7
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 208000017169 kidney disease Diseases 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000000223 Solitary Kidney Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000001099 axilla Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 238000005536 corrosion prevention Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-N iron;hydrochloride Chemical compound Cl.[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-N 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000009335 monocropping Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 229960000103 thrombolytic agent Drugs 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
【発明の詳細な説明】
〈産業上の利用分野〉
この発明は移植用腎臓の保存方法及び保存装置に関する
。DETAILED DESCRIPTION OF THE INVENTION <Industrial Application Field> The present invention relates to a method and apparatus for preserving a kidney for transplantation.
(従来の技術〉
腎臓疾患のため人工透析を余儀なくされた透析患者はそ
の90%以上が腎臓移植を希望していると考えられる。(Prior Art) It is thought that more than 90% of dialysis patients who are forced to undergo artificial dialysis due to kidney disease desire kidney transplantation.
しかし腎臓バンクには1箇の腎臓の貯えもなく、これで
はバンクと言うにはおこがましい存在であり、はとんど
実効が上っていないと想像される。最大の障害は臓器の
長期保存が出来ないためである。腎臓の場合は死体腎で
よいと言われているが、それでも死後数時間以内の移植
が好ましい事は言うまでもない、一方移植には血液型の
ほか年令、大きさ、疾患の有無などの条件があり、すす
んで自分の腎臓を提供する人は少ないと考えると患者に
とってほとんど希望がないと云わねばならない。However, the kidney bank does not have a single kidney stored in it, making it presumptuous to call it a bank, and one can imagine that it is not very effective. The biggest obstacle is that organs cannot be preserved for a long time. When it comes to kidneys, it is said that cadaveric kidneys can be used, but it goes without saying that it is still preferable to transplant the kidney within a few hours after death.On the other hand, there are several conditions for transplantation, such as blood type, age, size, presence of disease, etc. Considering that there are few people willing to donate their kidneys, it must be said that there is little hope for patients.
欧米の腎移植は比較的死体腎の場合が多いが、呼吸や循
環が停止して30分以内に腎臓を摘出し冷却した潅流液
で腎臓を洗い低温に保てば、1〜2日保存して移植する
ことも可能になっている、と言われる。その1〜2日が
保存期限の限界のようである。Kidney transplants in Europe and America are relatively often done with cadaveric kidneys, but if the kidney is removed within 30 minutes after breathing and circulation stop, washed with cooled perfusate, and kept at a low temperature, it can be stored for 1 to 2 days. It is said that it is now possible to transplant the system. It seems that 1 to 2 days is the limit of the shelf life.
〈発明が解決しようとする課題〉
死体腎の保存期限が十分長くなれば、提供者の善意によ
り腎臓パンクに各種血液型の腎臓が保存され、随時、適
応患者に移植することが出来る。<Problems to be Solved by the Invention> If the storage period of cadaveric kidneys becomes sufficiently long, kidneys of various blood types can be preserved in kidney punctures due to the goodwill of donors, and can be transplanted to suitable patients at any time.
本発明者はその可能性を探った。The inventor explored this possibility.
さて生体組織は一度生体固体から離れると、生体システ
ムが破壊されて組織の機能が失われるため、蛋白質、炭
水化物等の生体成分は直ちに分解をはじめる。これは生
体組織が生体固体から供給される何らかの物質によって
生体システムを保っていた事を意味する。従って、その
何らかの物質を人」二的にケえられるなら、人体から切
離された腎臓も(他の臓器も)長期間、生体機能を保ち
得るはずである。特に腎臓は外部から組織全体に物質を
供給しやすい構造である。Once a biological tissue is separated from a biological solid, biological components such as proteins and carbohydrates immediately begin to decompose because the biological system is destroyed and tissue functions are lost. This means that the biological system was maintained by some substance supplied from the biological solid. Therefore, if some of these substances can be removed from the human body, the kidneys (as well as other organs) should be able to maintain their biological functions for a long period of time after being removed from the human body. In particular, the kidney has a structure that allows substances to be easily supplied to the entire tissue from the outside.
こうして生体の生体機能を保たせる何らかの物質がある
に違いない、それが目的とする摘出腎保存の鍵である。In this way, there must be some kind of substance that maintains the biological functions of the living body, and this is the key to preserving the removed kidney.
という仮説を立て、その実現を研究目的とした。I formulated this hypothesis and aimed to realize it.
〈課題を解決するための手段〉
科学が進歩したとはいえ、生体システムに関する人類の
研究はまだ緒についたばかりで、生体機能を保たせる何
らかの物質がすでに解明されているとは思えなかったが
、とにかく文献を大々的に調べた。そして驚いたことに
、その物質がすでに発見されていたのである。その物質
が後述する二価、三価鉄塩である。〈Means for solving the problem〉 Even though science has advanced, human research on biological systems is still in its infancy, and I did not think that any substance that maintains biological functions had already been elucidated. Anyway, I researched the literature extensively. To their surprise, the substance had already been discovered. The substances are divalent and trivalent iron salts, which will be described later.
こうして生まれたこの発明の移植用腎臓の保存方法は二
価又は三価鉄塩の水溶液を潅流液として、摘出した腎臓
の内部を洗滌し、上記水溶液中に漬けて保存することを
特徴とする。The method for preserving a kidney for transplantation of the present invention thus developed is characterized by washing the inside of the removed kidney using an aqueous solution of a divalent or trivalent iron salt as a perfusate, and preserving the kidney by immersing it in the aqueous solution.
またこの発明の移植用腎臓の保存装置は、二価又は三価
鉄塩の水溶液を入れた水槽と、その槽内液を循環させて
濾過する自動濾過装置とからなり、
上記水槽の槽内液に、摘出した腎臓全体を漬け、上記濾
過装置から槽内液中に垂下し吸込口又は吐出口に、上記
腎臓の腎静脈、尿管と腎動脈との一方を接続し、他方を
槽内液中に開口させて、液の循環を続けるようにしたこ
とを特徴とする。The apparatus for preserving a kidney for transplantation of the present invention comprises a water tank containing an aqueous solution of a divalent or trivalent iron salt, and an automatic filtration device that circulates and filters the liquid in the tank. Then, the whole removed kidney is soaked and dripped into the bath liquid from the filtering device, and one of the renal vein, ureter and renal artery of the kidney is connected to the suction or discharge port, and the other is soaked in the bath liquid. It is characterized by having an opening inside so that the liquid can continue to circulate.
〈作 用〉
二価、三価鉄塩は各種のイオン反応を制御する。それは
生体機能を保持する働きをする。<Action> Divalent and trivalent iron salts control various ionic reactions. It functions to maintain biological functions.
その二価又は三価鉄塩の水溶液を潅流液として摘出腎の
内部を洗滌すれば、腎動脈、静脈、尿管の先端の腎小体
、尿細管に至るまで二価、三価鉄塩が滲透し、そのイオ
ン反応抑制作用により生体成分の分解を阻止し、生体機
能を保持させる。この状態でその腎臓を同じ二価又は三
価鉄塩の水溶液に漬けておく、この発明の保存方法によ
れば、摘出腎を長時間、冬眠さた状態に保存することが
出来る。If the inside of the removed kidney is washed with an aqueous solution of divalent or trivalent iron salts as a perfusate, divalent or trivalent iron salts will be present in the renal arteries, veins, renal corpuscles at the tips of the ureters, and even the renal tubules. It permeates through the body and prevents the decomposition of biological components through its ionic reaction inhibiting action, preserving biological functions. According to the preservation method of the present invention, in which the kidney is immersed in an aqueous solution of the same divalent or trivalent iron salt in this state, the removed kidney can be preserved in a hibernating state for a long period of time.
またこの発明の保存装置は、摘出腎の内部を洗滌する装
置と、洗滌ずみの摘出腎の保存装置とを兼ねる。洗滌の
際は、二価又は三価鉄塩の水溶液を入れた槽内に摘出腎
を沈め、その腎静脈、尿管と腎動脈との一方をポンプ側
に接続し、他方を槽内液中に開口させて濾過装置の循環
路に入れると、槽内の腋が摘出腎内部の隅々を回って、
濾過室で濾過された後、元の槽内へ戻る。摘出腎内部に
まだ血液、尿その他が残留している時は、濾過した液を
槽外に捨て、その分だけ新しい液を槽内に補給してもよ
い。Further, the storage device of the present invention serves both as a device for washing the inside of a removed kidney and as a storage device for the washed removed kidney. For washing, submerge the removed kidney in a bath containing an aqueous solution of divalent or trivalent iron salts, connect one side of its renal vein, ureter, and renal artery to the pump side, and submerge the other side in the solution in the bath. When the tank is opened and placed in the circulation path of the filtration device, the axilla in the tank goes around every corner of the inside of the excised kidney.
After being filtered in the filtration chamber, it returns to the original tank. If blood, urine, etc. still remain inside the removed kidney, the filtered fluid may be discarded outside the tank and new fluid may be replenished into the tank.
これを保存装置として使う時は、濾過装置を停めたま−
か、周期的に液を循環させるだけで、腎臓を冬眠させて
おく事ができる。濾過室のか材の交換、洗滌も当初だけ
でよい。When using this as a storage device, leave the filtration device turned off.
Alternatively, you can keep your kidneys in hibernation by simply circulating the fluid periodically. Replacement and cleaning of the material in the filtration chamber is only necessary at first.
く実 施 例)
この発明に用いる二価、三価鉄塩とその製造方法は特開
昭59−190226に公開されており、これは名古屋
大学農学部、山下昭治教授の30年に及ぶ研究の成果で
ある。Examples) The divalent and trivalent iron salts used in this invention and their production method are disclosed in JP-A-59-190226, and are the result of 30 years of research by Professor Shoji Yamashita of the Faculty of Agriculture, Nagoya University. It is.
その二価、三価鉄塩は、二価鉄と三価鉄との中間の性質
を示す鉄の塩酸塩、硫酸塩、燐酸塩、硝酸塩等の無機塩
、また蟻酸塩、酢酸塩、プロピオン酸塩等の有機塩であ
り、三価鉄の塩類を多量のカセイソーダ、水酸化カリウ
ム、水酸化リチウム、水酸化カルシウム等の強アルカリ
の水溶液に投入して、二価鉄のへの原子価変換を起こさ
せた場合、また二価鉄の塩類を多量の塩酸、硫酸等の強
酸の水溶液に投入して三価鉄への原子価変換を起こさせ
た場合の遷移形態として得られるものである。The divalent and trivalent iron salts include inorganic salts such as iron hydrochloride, sulfate, phosphate, and nitrate, which have intermediate properties between divalent iron and trivalent iron, as well as formate, acetate, and propionate. Organic salts such as trivalent iron salts are added to a large amount of strong alkali aqueous solution such as caustic soda, potassium hydroxide, lithium hydroxide, calcium hydroxide, etc. to convert the valence of trivalent iron to divalent iron. It is obtained as a transition form when a salt of divalent iron is introduced into a large amount of an aqueous solution of a strong acid such as hydrochloric acid or sulfuric acid to cause valence conversion to trivalent iron.
その公開公報の明細書には、この二価、三価鉄塩のイオ
ン反応抑制作用を利用した1、金属の防食、2、塩障害
の除去、3、連作障害土壌の改質、4、生体組織保存、
5、植物組織の再生、6、生体成分の非生物合成、7、
防腐、防かび作用、8、抗ウィルス作用、9、制がん作
用等の用例が具体的に示されている0本発明者は上の「
4、生体組織保存」の要件から、前述のように、これこ
そ生物の生体機能を保たせる物質である事を知った。The specifications of the published publication include 1. Corrosion prevention of metals, 2. Removal of salt damage, 3. Improvement of soil with continuous cropping damage, 4. tissue preservation,
5. Regeneration of plant tissues, 6. Abiotic synthesis of biological components, 7.
Specific examples of use such as antiseptic, antifungal action, 8. antiviral action, 9. anticancer action, etc. are shown.
4. From the requirements of ``Biological Tissue Preservation,'' as mentioned above, I learned that this is a substance that preserves the biological functions of living organisms.
その実施例は白ネズミなト殺後、直ちに筋肉組織をビン
に入れ、これに処理液を加え、一部室気層を残して密栓
し常温に静置した。同時に対照として筋肉組織に蒸留水
を加えて密栓したものを並べて静置した。In this example, immediately after killing a white rat, the muscle tissue was placed in a bottle, a treatment solution was added thereto, the bottle was sealed tightly and left at room temperature, leaving a partial room air layer. At the same time, as a control, distilled water was added to the muscle tissue and the tissue was sealed and left standing.
その結果、対照区は一週間後から組織が崩壊し、微生物
が繁殖して水がはげしく涸渇した。ところが処理区の検
体は組織が崩れず、微生物の繁殖が起こらず、液は透明
のま〜12年以上、最初の状態を保った。As a result, the tissue in the control plot collapsed after one week, microorganisms multiplied, and water rapidly dried up. However, the tissue of the samples from the treated area remained intact, microorganisms did not propagate, and the liquid remained clear for more than 12 years.
上記処理液は塩化鉄(■、■)の10−6M溶液IQm
(lにa−tocopherolおよびUbiquin
one(Co−enzyme Q7)各0.1gの混合
物を加えて懸濁させた後、ethanalで上記脂質部
分を集め、これに界面活性剤としてTween−20,
0,1gを加えて水に分散させ、順次蒸留水で希釈し、
脂質濃度で2 X 10−12M/Lの調整液としたも
のである。The above treatment solution is a 10-6M solution of iron chloride (■, ■) with an IQm
(L contains a-tocopherol and Ubiquin
One (Co-enzyme Q7) 0.1 g of each mixture was added and suspended, the above lipid portion was collected with ethanal, and Tween-20,
Add 0.1g and disperse in water, then dilute with distilled water sequentially.
The adjusted solution had a lipid concentration of 2 x 10-12 M/L.
なおこの発明は単に摘出腎の保存だけでなく、腎臓を人
体から切離して、体内における多様な活動をすべて休止
させ、その間に内部の残留物を除いて清掃し、隅々まで
二価、三価鉄塩を滲透させてそのイオン反応抑制による
前述の諸性用を効かせるから、単なる冬眠でなく1組織
の改善、細菌、ウィルス、がん細胞の制圧体制を整える
期間となることも十分考えられる。This invention does not simply preserve a removed kidney, but also removes the kidney from the human body, suspends all its various activities within the body, and during that time, removes and cleans the inside to remove divalent and trivalent substances. Since iron salts permeate through the body and suppress ionic reactions, the aforementioned properties are exerted, so it is quite conceivable that this is not just a period of hibernation, but a period of time for the improvement of one tissue and the establishment of a system for suppressing bacteria, viruses, and cancer cells. .
このように摘出した腎臓を安全に冬眠させる事が可能に
なると、腎疾患の治療のため患者の片方の腎臓を取出し
て冬眠させ、疾病に応じた治療薬を二価、三価鉄塩水溶
液に追加して、直接的に治療効果を上げた後、患者の体
内へ戻すことも可能になる。Once it became possible to safely hibernate a kidney that had been removed in this way, one kidney from a patient could be removed and hibernated in order to treat kidney disease, and therapeutic drugs depending on the disease could be added to an aqueous solution of divalent or trivalent iron salts. In addition, it will also be possible to directly increase the therapeutic effect and then return it to the patient's body.
次にこの発明の保存装置の実施例について説明する。Next, an embodiment of the storage device of the present invention will be described.
図は観賞魚用の自動濾過装置つき水槽を移植用腎臓の保
存装置に改造した実施例の概略図である。この例では水
槽1の上に自動濾過装置2が載っている。この例では電
磁振動ダイヤフラムポンプ3の吸込口4は槽底近くまで
下がっており、ホース5を介して、摘出腎lOの腎動脈
6に接続している。摘出腎10の腎静脈7の切断端と尿
管8は、液ll中に開口している。The figure is a schematic diagram of an embodiment in which an aquarium fish tank with an automatic filtration device is modified into a storage device for a kidney for transplantation. In this example, an automatic filtration device 2 is placed on top of the water tank 1. In this example, the suction port 4 of the electromagnetic oscillating diaphragm pump 3 is lowered to near the bottom of the tank, and is connected to the renal artery 6 of the excised kidney 10 via a hose 5. The cut end of the renal vein 7 and the ureter 8 of the excised kidney 10 open into the fluid 11.
液11は熱論、二価又は三価鉄塩の水溶液であるが、当
初は血栓溶解剤を加えて内部洗浄の完全を期すとよい。The liquid 11 is an aqueous solution of divalent or trivalent iron salt, and it is preferable to add a thrombolytic agent initially to ensure complete internal cleaning.
ポンプモータのさし込み3aを電源に接続して始動させ
ると、吸込口4が陰圧になって、腎静脈7、尿管8から
摘出腎10内の残留物を吸い出す。When the pump motor insert 3a is connected to a power source and started, the suction port 4 becomes negative pressure, and the residue inside the excised kidney 10 is sucked out from the renal vein 7 and ureter 8.
そしてそのあとに腎動脈6から流入した上記水溶液11
が満たされ、順次吸込口4へ向かう、吸込まれた残留物
、残液等を含む液11は矢印のように上昇して、濾過装
置2のか過室12を沈下する間に濾過される。After that, the aqueous solution 11 flowing in from the renal artery 6
The liquid 11 containing the suctioned residue, remaining liquid, etc. is filled and sequentially heads toward the suction port 4, rising as shown by the arrow and being filtered while descending through the filtering chamber 12 of the filtration device 2.
濾過室12の底面の穴から流出した液は矢印のように液
溜り13から、導出管14により水槽lへ流下する。あ
るいは導出管14の下端にホースを付けて槽外へ排出し
てもよい。The liquid flowing out from the hole in the bottom of the filtration chamber 12 flows down from the liquid reservoir 13 to the water tank l through the outlet pipe 14 as shown by the arrow. Alternatively, a hose may be attached to the lower end of the outlet pipe 14 to discharge the water out of the tank.
上記実施例は既製品を利用したためか過室12が簡単な
ものになっているが、これはより大きくして槽外に設け
、炉材も今後研究を進める予定である。In the above embodiment, the overchamber 12 is simple, probably because a ready-made product is used, but it is planned to be made larger and installed outside the tank, and research on furnace materials will be conducted in the future.
また超音波振動装置を加えて、摘出腎内部を洗浄する間
だけ超音波を加えるとか、流れを時々逆にするとか、速
度を変えるとか、液温を変える等の工夫も考えられる。Other ideas include adding an ultrasonic vibration device to apply ultrasonic waves only while cleaning the inside of the removed kidney, occasionally reversing the flow, changing the speed, and changing the temperature of the liquid.
またこの装置により摘出胃内部の二価、三価鉄塩水溶液
を生理的食塩水に換える番も可能である。This device also allows the divalent and trivalent iron salt aqueous solution inside the excised stomach to be replaced with physiological saline.
〈発明の効果〉
この発明は、腎臓移植は摘出後、遅くても1〜2日以内
に行わねばならなかった摘出腎保存技術の遅れを大きく
改善した。<Effects of the Invention> This invention greatly improves the delay in kidney preservation techniques, which required kidney transplantation to be performed within 1 to 2 days at the latest after removal.
腎疾患を持つ工学博士の一人として本発明者は、現状で
は無に等しい摘出腎保存技術の必要を痛感し、生体組織
が生体個体から離れると機能を失うのは生体個体から組
織−1送られる何らかの物質があるはずで、その物質を
補給して袷れば摘出腎も機能を失わずに保存できる、と
いう仮説を立てた。そして、この発明で、その正当性を
立証し得た。As a doctor of engineering with kidney disease, the present inventor is acutely aware of the need for techniques for preserving kidneys that are currently ineffective. He hypothesized that there must be some kind of substance, and that if the substance was supplied and covered, the removed kidney could be preserved without losing its function. With this invention, we have been able to prove its validity.
すなわち研究、調査により本発明者は、名古屋大学山王
教授が開発した、二価、三価鉄塩水溶液こそ上記仮説上
の物質に当たると認め、これを摘出腎の内部洗浄液、浸
漬液とするこの発明とし摘出腎保存技術の基礎知識を提
供し得た。That is, through research and investigation, the present inventor recognized that the divalent and trivalent iron salt aqueous solution developed by Professor Sanno of Nagoya University corresponds to the above hypothetical substance, and developed this invention in which this is used as an internal cleaning solution and soaking solution for a removed kidney. We were able to provide basic knowledge on kidney removal techniques.
二価、三価鉄塩の水溶液により内部を洗浄され漬けられ
た摘出腎は、イオン反応を抑制されるため分解し得す、
生体機能を保ったま〜冬眠状態を続ける。従ってこれを
人体に戻せば、血液の流入により酸素とエネルギを受け
て目を覚まし、本来の働きを始めるのである。その冬眠
中、つまり保存中にイオン反応抑制による分解防止にと
(まらず、進んで摘出腎の患部を治療する道も開けた。The removed kidney, which has been internally cleaned and soaked in an aqueous solution of divalent and trivalent iron salts, can decompose because the ionic reaction is suppressed.
It continues to hibernate while maintaining its biological functions. Therefore, when it is returned to the human body, it receives oxygen and energy from the influx of blood, wakes up, and begins its original function. During its hibernation, or storage, it was possible to prevent decomposition by suppressing ionic reactions.
またこの発明の移植用腎臓の保存装置は二価、三価鉄塩
水溶液に摘出腎を漬けたまへ、その水溶液を腎内部へ滲
透、循環させ、これを濾過する事を自動的に続けるので
、摘出後直ちにこの保存装置に入れる事により内部洗浄
が自動的に行われ、その後はそのま\槽内に摘出腎を漬
けて長期保存する事も、また槽内液に薬品を追加して治
療効果をあげることも出来る。In addition, the transplant kidney preservation device of the present invention automatically continues soaking the excised kidney in a divalent or trivalent iron salt aqueous solution, permeating and circulating the aqueous solution into the kidney, and filtering it. Immediately after the kidney is removed, it is placed in this storage device to automatically clean the inside of the kidney, and after that, the kidney can be soaked in the tank for long-term storage, or drugs can be added to the solution in the tank to improve the therapeutic effect. You can also give
この発明により腎パンクに各種、多数の摘出腎を保存し
、データをコンピュータに入れて待機させられる事、ま
た病んだ腎臓を一時摘出して治療する新しい道を開いた
事は、世界の腎臓疾患者仲間に多大の福音をもたらすも
のである。This invention made it possible to store a large number of removed kidneys of various types in cases of kidney failure, put the data into a computer, and put them on standby, and opened a new way to temporarily remove and treat diseased kidneys. It brings much good news to fellow believers.
図はこの発明の移植用腎臓の保存装置の一実施例の説明
図で、図中、1は水槽、2は自動濾過装置である。The figure is an explanatory view of one embodiment of the kidney transplantation preservation device of the present invention, in which 1 is a water tank and 2 is an automatic filtration device.
Claims (2)
した腎臓の内部を洗滌し、上記水溶液中に漬けて保存す
ることを特徴とする移植用腎臓の保存方法。(1) A method for preserving a kidney for transplantation, which comprises washing the inside of the removed kidney using an aqueous solution of a divalent or trivalent iron salt as a perfusate, and preserving the kidney by immersing it in the aqueous solution.
槽内液を循環させて濾過する自動濾過装置とからなり、 上記水槽の槽内液に、摘出した腎臓全体を漬け、上記濾
過装置から槽内液中に垂下した吸込口又は吐出口に、上
記腎臓の腎静脈、尿管と腎動脈との一方を接続し、他方
を槽内液中に開口させて、液の循環を続けるようにした
ことを特徴とする移植用腎臓の保存装置。(2) It consists of a water tank filled with an aqueous solution of divalent or trivalent iron salts and an automatic filtration device that circulates and filters the solution in the tank, and soaks the whole excised kidney in the solution in the tank, One of the renal veins, ureters and renal arteries of the kidney is connected to the suction or discharge port hanging down from the filtration device into the tank liquid, and the other is opened into the tank liquid to circulate the liquid. A storage device for a kidney for transplantation, characterized in that the storage device continues to carry out the following steps.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16426290A JPH0454101A (en) | 1990-06-25 | 1990-06-25 | Preservation of kidney for implantation and preserving device of same kidney |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16426290A JPH0454101A (en) | 1990-06-25 | 1990-06-25 | Preservation of kidney for implantation and preserving device of same kidney |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0454101A true JPH0454101A (en) | 1992-02-21 |
Family
ID=15789748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16426290A Pending JPH0454101A (en) | 1990-06-25 | 1990-06-25 | Preservation of kidney for implantation and preserving device of same kidney |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0454101A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4835688A (en) * | 1971-09-02 | 1973-05-25 | ||
| JPS59190226A (en) * | 1983-04-11 | 1984-10-29 | Shoji Yamashita | Bivalent and trivalent iron salt and their preparation |
-
1990
- 1990-06-25 JP JP16426290A patent/JPH0454101A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4835688A (en) * | 1971-09-02 | 1973-05-25 | ||
| JPS59190226A (en) * | 1983-04-11 | 1984-10-29 | Shoji Yamashita | Bivalent and trivalent iron salt and their preparation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7981596B2 (en) | Tissue preservation with a salt solution isotonic with interstitial fluids | |
| Rozga et al. | Development of a hybrid bioartificial liver | |
| Kolff et al. | The artificial kidney: a dialyser with a great area. 1944. | |
| US4235231A (en) | Portable artificial kidney | |
| JP2849473B2 (en) | Method and apparatus for storing organs, body ends and body fragments | |
| JP2535147B2 (en) | Disinfectant composition | |
| WO1988005261A1 (en) | Total organ perfusion system | |
| CA2620328C (en) | Machine perfusion of tissue grafts for transplantation | |
| JP2004508821A (en) | Bioreactor equipment | |
| WO1991014364A1 (en) | Microperfusion apparatus | |
| Daniel et al. | Extracorporeal perfusion of isolated organs of large animals-Bridging the gap between in vitro and in vivo studies | |
| JPH0454101A (en) | Preservation of kidney for implantation and preserving device of same kidney | |
| JP2019527534A (en) | Methods for cleansing, detoxifying and preserving cells and tissues of fresh animal livers | |
| Lowsley et al. | Artificial kidney: Preliminary report | |
| CN113677200A (en) | Methods and devices for repairing organs | |
| JP2006087421A (en) | Method for thawing and seasoning frozen fish and shellfish, and thawing apparatus | |
| WO2014179113A1 (en) | Formulations containing poly (0-2-hydroxyethyl) starch for increasing the oxygen-content, stability and shelf life of an organ and tissue preservation solution | |
| RU2134962C1 (en) | Method and device for preservation of organs, extremities and tissue grafts | |
| CN203159269U (en) | Multifunctional ecological processor | |
| Naruse et al. | Development of a new extracorporeal whole-liver perfusion system | |
| Gordon et al. | The first successful haemodialysis | |
| RU2126685C1 (en) | Method of preparing pig spleen xenocells suspension for using in patient treatment with pathological change of immune status | |
| JPS5946610B2 (en) | Ascites treatment device | |
| SU938873A1 (en) | Composition for preservation of donor kidneys | |
| WO2007043698A1 (en) | Solution for preserving liver |